The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy
Open accessAbstract
BACKGROUND: Dementia with Lewy bodies (DLB) is a common form of dementia. The presence of Alzheimer's disease (AD) pathology modifies the clinical features of DLB, making it harder to distinguish DLB from AD clinically during life. Clinical diagnostic criteria for DLB applied at presentation can fail to identify up to 50% of cases. Our aim was to determine, in a series of patients with dementia in whom autopsy confirmation of diagnosis was available, whether functional imaging of the nigrostriatal pathway improves the accuracy of diagnosis compared with diagnosis by means of clinical criteria alone. METHODS: A single photon emission computed tomography (SPECT) scan was carried out with a dopaminergic presynaptic ligand [123I]-2beta-carbometoxy-3beta-(4-iodophenyl)-N-(3-fluoropropyl) nortropane (FP-CIT; ioflupane) on a group of patients with a clinical diagnosis of DLB or other dementia. An abnormal scan was defined as one in which right and left posterior putamen binding, measured semiquantitatively, was more than 2 SDs below the mean of the controls. RESULTS: Over a 10 year period it was possible to collect 20 patients who had been followed from the time of first assessment and time of scan through to death and subsequent detailed neuropathological autopsy. Eight patients fulfilled neuropathological diagnostic criteria for DLB. Nine patients had AD, mostly with coexisting cerebrovascular disease. Three patients had other diagnoses. The sensitivity of an initial clinical diagnosis of DLB was 75% and specificity was 42%. The sensitivity of the FP-CIT scan for the diagnosis of DLB was 88% and specificity was 100%. CONCLUSION: FP-CIT SPECT scans substantially enhanced the accuracy of diagnosis of DLB by comparison with clinical criteria alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationMirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Self-citationConsortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G. G., & Heyman, A. (2002) · Principles and Practice of Geriatric Psychiatry · doi:10.1002/0470846410.ch42(iii · Cited by 2,410
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (2011) · Neurology · doi:10.1212/01.wnl.0000400650.92875.cf · Cited by 1,495
McKeith, I. G. (2004) · Europe PMC (PubMed Central) · Cited by 756
Self-citationMcKeith, I. G. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s347 · Cited by 625
Self-citationMcKeith, I., Mintzer, J., Aarsland, D., Burn, D., Chiu, H., Cohen-Mansfield, J., Dickson, D., Dubois, B., Duda, J. E., Feldman, H., et al. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00619-7 · Cited by 618
Self-citationMinoshima, S., Foster, N. L., Sima, A. A. F., Frey, K. A., Albin, R. L., & Kuhl, D. E. (2001) · Annals of Neurology · doi:10.1002/ana.1133 · Cited by 560
Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies
McKeith, I. G., Ballard, C. G., Perry, R. H., Ince, P. G., O’Brien, J. T., Neill, D., Lowery, K., Jaros, E., Barber, R., Thompson, P., et al. (2000) · Neurology · doi:10.1212/wnl.54.5.1050 · Cited by 459
Self-citationO'Brien, J. T., Colloby, S., Fenwick, J., Williams, E. D., Firbank, M., Burn, D., Aarsland, D., & McKeith, I. G. (2004) · Archives of Neurology · doi:10.1001/archneur.61.6.919 · Cited by 334
Self-citationWalker, Z. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.2.134 · Cited by 279
Self-citationBooij, J., Speelman, J. D., Horstink, M. W. I. M., & Wolters, E. C. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590000460 · Cited by 264
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
(2005) · Neurology · doi:10.1212/wnl.65.12.1992-a · Cited by 240
Martí-Massó, J. F., & Martínez, J. R. (2000) · PubMed · Cited by 231
Clinical and quantitative pathologic correlates of dementia with Lewy bodies
Gómez-Tortosa, E., Newell, K., Irizarry, M. C., Albert, M., Growdon, J. H., & Hyman, B. T. (1999) · Neurology · doi:10.1212/wnl.53.6.1284 · Cited by 204
Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: A comparison
Walker, Z., Costa, D. C., Walker, R. W. H., Lee, L., Livingston, G., Jaros, E., Perry, R., McKeith, I., & Katona, C. L. E. (2004) · Neurology · doi:10.1212/01.wnl.0000123248.39847.1d · Cited by 171
Self-citationDonnemiller, E., Heilmann, J., Wenning, G. K., Berger, W., Decristoforo, C., Moncayo, R., Poewe, W., & Ransmayr, G. (1997) · European Journal of Nuclear Medicine · doi:10.1007/bf01728771 · Cited by 167
[123I]‐FP/CIT SPECT imaging for distinguishing drug‐induced parkinsonism from Parkinson's disease
Lorberboym, M., Treves, T. A., Melamed, E., Lampl, Y., Hellmann, M. A., & Djaldetti, R. (2005) · Movement Disorders · doi:10.1002/mds.20748 · Cited by 154
Research Evaluation and Prospective Diagnosis of Dementia With Lewy Bodies
López, O. L., Becker, J. T., Kaufer, D., Hamilton, R. L., Sweet, R. A., Klunk, W. E., & DeKosky, S. T. (2002) · Archives of Neurology · doi:10.1001/archneur.59.1.43 · Cited by 154
18 F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies
Hu, X. S., Okamura, N., Arai, H., Higuchi, M., Matsui, T., Tashiro, M., Shinkawa, M., Itoh, M., Ido, T., & Sasaki, H. (2000) · Neurology · doi:10.1212/wnl.55.10.1575 · Cited by 124
A pathological study of the association between Lewy body disease and Alzheimer's disease.
Gibb, W. R. G., Mountjoy, C. Q., Mann, D. M. A., & Lees, A. J. (1989) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.6.701 · Cited by 77
In-vivo demonstration of dopaminergic degeneration in dementia with Lewy bodies
Walker, Z., Costa, D. C., Ince, P. G., McKeith, I. G., & Katona, C. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01178-2 · Cited by 72
Self-citationMateos, J. J., Lomeña, F., Parellada, E., et al. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0570-5 · Cited by 65
Walker, Z., Costa, D. C., Janssen, A. G., Walker, R. W. H., Livingstone, G., & Katona, C. (1997) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00841397 · Cited by 61
Self-citationColloby, S. J., O'Brien, J. T., Fenwick, J. D., Firbank, M., Burn, D. J., McKeith, I. G., & Williams, E. D. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.06.045 · Cited by 60
Self-citationStriatal monoamine terminals in Lewy body dementia and Alzheimer's disease
Gilman, S., Koeppe, R. A., Little, R. J. A., An, H., Junck, L., Giordani, B., Persad, C. C., Heumann, M., & Wernette, K. (2004) · Annals of Neurology · doi:10.1002/ana.20088 · Cited by 59
Non‐uniformity in the regional pattern of Lewy pathology in brains of dementia with Lewy bodies
Yamamoto, R., Iseki, E., Marui, W., Togo, T., Katsuse, O., Kato, M., Isojima, D., Akatsu, H., Kosaka, K., & Arai, H. (2005) · Neuropathology · doi:10.1111/j.1440-1789.2005.00627.x · Cited by 35
Lavalaye, J., Knol, R. J. J., de Bruin, K. M., Reneman, L., Janssen, A. G. M., & Booij, J. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050044 · Cited by 34
The frequency of Lewy bodies in a consecutive autopsy series.
Cf, L., & Hb, H. (1998) · PubMed · Cited by 30
Neuropathological Criteria for the Diagnosis of Alzheimer’s Disease: Are We Really Ready Yet?
Ball, M. J., & MURDOCH, G. H. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00074-2 · Cited by 28
A pathological study of the association between Lewy body disease and Alzheimer's disease.
Gibb, W. R. G., Mann, D. M. A., Mountjoy, C. Q., & Lees, A. J. (1990) · PubMed · Cited by 10
Cited by
Revising the definition of Alzheimer's disease: a new lexicon
Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barberger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70223-4 · Cited by 1,869
Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
Erkkinen, M. G., Kim, M.-O., & Geschwind, M. D. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a033118 · Cited by 1,124
Simuni, T., Chahine, L. M., Poston, K., Brumm, M., Buracchio, T., Campbell, M., Chowdhury, S., Coffey, C., Concha-Marambio, L., Dam, T., et al. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00405-2 · Cited by 629
Walker, Z., Possin, K. L., Boeve, B. F., & Aarsland, D. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00462-6 · Cited by 592
Self-citationThe use of PET in Alzheimer disease
Nordberg, A., Rinne, J. O., Kadir, A., & Långström, B. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.217 · Cited by 449
Metadata
- Authors
- Walker, Z., Jaros, E., Walker, R. W. H., Lee, L., Costa, D. C., Livingston, G., Ince, P. G., Perry, R., McKeith, I., & Katona, C. L. E.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2007-11-01
- Volume
- 78
- Issue
- 11
- Pages
- 1176-1181
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2022475351
- Cited by
- 279
- References
- 35
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.